论文部分内容阅读
采用碘标记单克隆抗体O_(C125)固相免疫测定法,测定30例子宫肌瘤、30例子宫腺肌症、15例子宫肉瘤患者血清C_(A125)水平。结果显示:手术前后子宫肌瘤患者血清C_(A125)均值差无显著性(P>0.05)。子宫腺肌症患者血清C_(A125)含量术前明显高于术后(P<0.05)。子宫肉瘤患者术前血清C_(A125)值均大于35u/ml。本文初步探讨了血清C_(A125)含量对子宫肌瘤、子宫腺肌症及子宫肉瘤患者的辅助诊断,症情监测及预后价值。
Serum C_ (A125) levels in 30 cases of uterine fibroids, 30 cases of adenomyosis and 15 cases of uterine sarcoma were determined by iodine labeled monoclonal antibody O_ (C125) solid phase immunoassay. The results showed that there was no significant difference in mean C_ (A125) serum levels of uterine fibroids before and after operation (P> 0.05). Serum C_ (A125) levels in patients with adenomyosis were significantly higher than those before operation (P <0.05). Preoperative serum C_ (A125) values of uterine sarcoma patients were greater than 35u / ml. This paper preliminary study of serum C_ (A125) content of uterine fibroids, adenomyosis and uterine sarcoma in patients with diagnosis, symptom monitoring and prognostic value.